A recent U.S. military test at Florida’s Eglin Air Force Base exposed significant issues with Anduril Industries’ Altius drones after two units crashed during separate flights. According to an Air Force test summary, one drone plunged roughly 8,000 feet moments after release, while another spiraled into the ground during a later demonstration. These incidents, reported for the first time, come as Anduril positions itself as a leading force in next-generation defense technology.
Backed by surging investment and valued at $30.5 billion, Anduril has promoted its Altius drones as combat-ready assets capable of surveillance, long-range strikes, and multi-platform launches. Founder Palmer Luckey has touted their battlefield success in Ukraine, claiming the drones have eliminated high-value Russian targets. The company says it has shipped hundreds of systems to Kyiv and recently delivered additional models to Taiwan.
However, interviews with former employees, military officials, and Ukrainian drone operators reveal gaps between Anduril’s claims and real-world performance. Western drones overall have played a limited role in Ukraine, with officials noting that 96% of drones deployed in 2024 were domestically produced. Sources say Anduril’s earlier Ghost drones struggled against Russian electronic warfare, prompting the development of the Ghost X. Yet even the updated model has faced setbacks, including a widely circulated crash at a U.S. Army exercise in Germany.
Anduril maintains that such failures are expected during aggressive testing cycles meant to accelerate innovation. The company points to thousands of flight hours and ongoing software updates conducted alongside soldiers in combat zones. The U.S. military acknowledges that system failures are common when experimenting with emerging technologies, but the timing is notable: the Pentagon announced a contract worth up to $50 million for additional Altius drones on the same day as the failed demonstration.
Despite recent challenges, Anduril continues expanding its autonomous weapons portfolio—from advanced warship projects to new high-end surveillance drones. As modern warfare shifts toward mass-produced, rapidly iterated systems, the performance of platforms like Altius and Ghost remains under close scrutiny from the Pentagon, Ukraine, and global defense partners.


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



